Victory Capital Management Inc Innoviva, Inc. Transaction History

Victory Capital Management Inc

  • $98.4 Billion
  • Q1 2024

A detailed history of Victory Capital Management Inc transactions in Innoviva, Inc. stock. As of the latest transaction made, Victory Capital Management Inc holds 83,232 shares of INVA stock, worth $1.37 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
83,232
Previous 12,600 560.57%
Holding current value
$1.37 Million
Previous $202,000 527.72%
% of portfolio
0.0%
Previous 0.0%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 03, 2024
BUY
$14.56 - $16.78 $1.03 Million - $1.19 Million
70,632 Added 560.57%
83,232 $1.27 Million
Q4 2023

Feb 05, 2024
BUY
$12.32 - $16.27 $19,194 - $25,348
1,558 Added 14.11%
12,600 $202,000
Q3 2023

Nov 06, 2023
SELL
$12.37 - $13.89 $5,974 - $6,708
-483 Reduced 4.19%
11,042 $143,000
Q2 2023

Jul 27, 2023
SELL
$11.39 - $13.72 $132,636 - $159,769
-11,645 Reduced 50.26%
11,525 $146,000
Q1 2023

May 02, 2023
SELL
$10.73 - $13.6 $1.13 Million - $1.44 Million
-105,572 Reduced 82.0%
23,170 $260,000
Q4 2022

Feb 10, 2023
BUY
$11.8 - $13.78 $131,239 - $153,261
11,122 Added 9.46%
128,742 $1.71 Million
Q4 2022

Feb 09, 2023
BUY
$11.8 - $13.78 $362,401 - $423,211
30,712 Added 35.34%
117,620 $1.56 Million
Q3 2022

Nov 02, 2022
BUY
$11.61 - $15.22 $106,231 - $139,263
9,150 Added 11.77%
86,908 $1.01 Million
Q2 2022

Aug 01, 2022
SELL
$14.32 - $19.88 $210,103 - $291,679
-14,672 Reduced 15.87%
77,758 $1.15 Million
Q1 2022

May 04, 2022
SELL
$15.39 - $20.25 $48,847 - $64,273
-3,174 Reduced 3.32%
92,430 $1.59 Million
Q4 2021

Feb 07, 2022
SELL
$15.91 - $18.72 $198,636 - $233,719
-12,485 Reduced 11.55%
95,604 $1.65 Million
Q3 2021

Nov 02, 2021
SELL
$13.06 - $17.24 $240,552 - $317,543
-18,419 Reduced 14.56%
108,089 $1.81 Million
Q2 2021

Aug 03, 2021
BUY
$11.45 - $13.96 $4,934 - $6,016
431 Added 0.34%
126,508 $1.7 Million
Q1 2021

May 04, 2021
BUY
$11.06 - $12.87 $249,015 - $289,768
22,515 Added 21.74%
126,077 $1.51 Million
Q4 2020

Feb 01, 2021
SELL
$9.33 - $12.48 $43,851 - $58,656
-4,700 Reduced 4.34%
103,562 $1.28 Million
Q3 2020

Nov 09, 2020
BUY
$10.33 - $14.49 $19,151 - $26,864
1,854 Added 1.74%
108,262 $1.13 Million
Q2 2020

Aug 07, 2020
BUY
$11.49 - $15.26 $726,466 - $964,828
63,226 Added 146.42%
106,408 $1.49 Million
Q1 2020

May 04, 2020
BUY
$8.11 - $15.23 $122,882 - $230,764
15,152 Added 54.06%
43,182 $508,000
Q4 2019

Feb 06, 2020
BUY
$10.28 - $14.38 $22,893 - $32,024
2,227 Added 8.63%
28,030 $397,000
Q4 2019

Feb 04, 2020
BUY
$10.28 - $14.38 $81,931 - $114,608
7,970 Added 44.69%
25,803 $356,000
Q3 2019

Nov 12, 2019
BUY
$10.05 - $14.55 $112,379 - $162,698
11,182 Added 168.13%
17,833 $188,000
Q2 2019

Aug 15, 2019
SELL
$13.1 - $14.95 $4.99 Million - $5.69 Million
-380,898 Reduced 98.28%
6,651 $97,000
Q1 2019

May 03, 2019
SELL
$13.69 - $20.06 $744,256 - $1.09 Million
-54,365 Reduced 12.3%
387,549 $5.44 Million
Q4 2018

Feb 05, 2019
SELL
$13.96 - $18.26 $471,275 - $616,439
-33,759 Reduced 7.1%
441,914 $7.71 Million
Q3 2018

Nov 01, 2018
SELL
$13.63 - $15.7 $170,061 - $195,888
-12,477 Reduced 2.56%
475,673 $7.25 Million
Q2 2018

Aug 02, 2018
SELL
$13.44 - $17.59 $2.06 Million - $2.69 Million
-153,123 Reduced 23.88%
488,150 $6.74 Million
Q1 2018

May 04, 2018
BUY
$13.8 - $16.99 $679,525 - $836,604
49,241 Added 8.32%
641,273 $10.7 Million
Q4 2017

Feb 01, 2018
BUY
$11.73 - $14.75 $6.82 Million - $8.57 Million
581,349 Added 5441.81%
592,032 $8.4 Million
Q3 2017

Oct 27, 2017
BUY
$12.06 - $14.12 $8,634 - $10,109
716 Added 7.18%
10,683 $151,000
Q2 2017

Aug 07, 2017
BUY
N/A
9,967
9,967 $128,000

Others Institutions Holding INVA

# of Institutions
220
Shares Held
78.8M
Call Options Held
45.9K
Put Options Held
14.1K
View Full List

About Innoviva, Inc.

INVA Quotes by TradingView
  • Ticker INVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 69,706,000
  • Market Cap $1.14B
  • Description
  • Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...
More about INVA
Track This Portfolio

Track Victory Capital Management Inc Portfolio

Follow Victory Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Victory Capital Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email